via thecontrail.com

The Gardasil HPV vaccine is probably the most controversial vaccine in the world right now, with many countries withdrawing their approval of the dangerous vaccine.

Outside of the U.S. parents and organizations have taken legal action against Merck for injuries and deaths due to Gardasil, and in France one doctor who previously worked for Merck predicted that Gardasil would become “the greatest medical scandal of all time.”

Are postpartum 16 to 26 year old mothers in a position to decide to take part in Gardasil vaccine trials 0-4 days after giving birth?

UPDATE

Since this story was published representatives from SaneVax, Inc., one of the Internet’s leading portals on the dangers of the Gardasil vaccine, notified us that there have been entries into the Vaccine Adverse Event Reporting System (VAERS) database citing instances where breast-fed healthy infants have died after their mothers were vaccinated with the Gardasil vaccine. One such case is VAERS ID: 398755

Information has been received from a physician for the pregnancy registry for GARDASIL, concerning a female who on 01-SEP-2010 was vaccinated with the first dose of GARDASIL (lot number not reported) intramuscularly while breastfed her baby was 40 day old (WAES 1009USA00625), it was reported that the mother”s and baby”s health were good (well controlled). On 02-SEP-2010, in the morning, the baby”s condition was still good but in the afternoon the condition suddenly drop. The family immediately took the baby to hospital and it did not help since the baby died shortly after that. The cause of death was not reported, it was also reported as “not recovered from death”.

Could it be that nursing mothers who are vaccinated with Gardasil are passing on the contents of the vaccine to their infants through their breast milk?

The University of Alabama at Birmingham (UAB) in collaboration with Merck pharmaceutical company is planning to conduct Gardasil 9 vaccine trials on postpartum mothers between the ages of 16 to 26 immediately after giving birth at the UAB hospital.

According to ClinicalTrials.gov, the desired outcome of this study is to have more young women vaccinated with the Gardasil vaccine, because they do not believe enough young women are being vaccinated:

Due to low HPV vaccine uptake in the US, innovative approaches to vaccinating vulnerable populations are necessary in order to maximize the cancer prevention potential of this vaccine.

Previous studies on the Gardasil vaccine have shown that young women who are in the hospital due to giving birth are open to receiving the Gardasil vaccine, particularly Hispanic populations:

The puerperium is a time period when women are engaged in the healthcare system and have almost universal access to affordable health care.

Two prior studies have shown that postpartum HPV vaccination is acceptable to patients, and high rates of vaccination were achieved in these primarily Hispanic populations.

Merck and UAB want to test the vaccine on 16 to 26 year old postpartum mothers because “the immune response in young women is less robust than in adolescents,” and because “no studies have examined immunogenicity in postpartum women specifically.”

READ MORE

https://nexusnewsfeed.com/article/human-rights/merck-and-uab-recruiting-16-to-26-year-old-mothers-who-just-gave-birth-to-enroll-in-gardasil-9-vaccine-trials/